FDA Clearance Tracker · P170003
LUTONIX® 035 Drug Coated Balloon PTA Catheter, Model 9010
Last checked: Nov 19, 2026Latest source record: Aug 25, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Aug 25, 2017
Approved
Time to decision
214 days
Received Jan 23, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170003
- Device name
- LUTONIX® 035 Drug Coated Balloon PTA Catheter, Model 9010
- Applicant
- Lutonix
- Applicant location
- New Hope, MN
- Received
- Jan 23, 2017
- Decided
- Aug 25, 2017
- Decision
- Approved
- Supplements
- 24 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the LUTONIX® 035 Drug Coated Balloon PTA Catheter. This device is indicated for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of stenotic lesions in dysfunctional native arteriovenous dialysis fistulae that are 4 mm to 12 mm in diameter and up to 80 mm in length.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PRC (Drug-coated peripheral transluminal angioplasty catheter).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Lutonix
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- LUTONIX 035 DRUG COATED BALLOON PTA CATHETERPMA supplement
P130024-S009 · Decided Feb 7, 2017 · 400 days after receipt · Panel Track
Device type: Drug-Eluting Peripheral Transluminal Angioplasty Catheter (ONU) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.